EU Commitments in Pharmaceutical Mergers & Acquisitions - Merging Parties' Guidelines on the Notification of Complex Concentrations. Towards a Fairer System
Commitments under the EU merger control have been used as the tool to balance the preservation of fierce competition in the single market and the positive impact of M&A activity both in Europe and worldwide. Infrequently, the complex competitive analysis of concentrations results in the finding of serious doubts as to the compatibility of the transaction with the common market. In order to sol